These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

439 related articles for article (PubMed ID: 28760474)

  • 1. Impact of Postoperative Liver Dysfunction on Survival After Left Ventricular Assist Device Implantation.
    Majumder K; Spratt JR; Holley CT; Roy SS; Cogswell RJ; Liao K; John R
    Ann Thorac Surg; 2017 Nov; 104(5):1556-1562. PubMed ID: 28760474
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of Diabetes Mellitus on Outcomes in Patients After Left Ventricular Assist Device Implantation.
    Usoh CO; Sherazi S; Szepietowska B; Kutyifa V; McNitt S; Papernov A; Wang M; Alexis JD
    Ann Thorac Surg; 2018 Aug; 106(2):555-560. PubMed ID: 29577927
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Model of End-Stage Liver Disease-eXcluding International Normalized Ratio (MELD-XI) Scoring System to Predict Outcomes in Patients Who Undergo Left Ventricular Assist Device Implantation.
    Critsinelis A; Kurihara C; Volkovicher N; Kawabori M; Sugiura T; Manon M; Wang S; Civitello AB; Morgan JA
    Ann Thorac Surg; 2018 Aug; 106(2):513-519. PubMed ID: 29626453
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improved survival and decreasing incidence of adverse events with the HeartMate II left ventricular assist device as bridge-to-transplant therapy.
    John R; Kamdar F; Liao K; Colvin-Adams M; Boyle A; Joyce L
    Ann Thorac Surg; 2008 Oct; 86(4):1227-34; discussion 1234-5. PubMed ID: 18805167
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Postoperative right ventricular failure after left ventricular assist device placement is predicted by preoperative echocardiographic structural, hemodynamic, and functional parameters.
    Raina A; Seetha Rammohan HR; Gertz ZM; Rame JE; Woo YJ; Kirkpatrick JN
    J Card Fail; 2013 Jan; 19(1):16-24. PubMed ID: 23273590
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prolonged continuous-flow left ventricular assist device support and posttransplantation outcomes: A new challenge.
    Fukuhara S; Takeda K; Polanco AR; Takayama H; Naka Y
    J Thorac Cardiovasc Surg; 2016 Mar; 151(3):872-880.e5. PubMed ID: 26896362
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Echocardiographic predictors of adverse outcomes after continuous left ventricular assist device implantation.
    Topilsky Y; Oh JK; Shah DK; Boilson BA; Schirger JA; Kushwaha SS; Pereira NL; Park SJ
    JACC Cardiovasc Imaging; 2011 Mar; 4(3):211-22. PubMed ID: 21414567
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Echocardiographic variables after left ventricular assist device implantation associated with adverse outcome.
    Topilsky Y; Hasin T; Oh JK; Borgeson DD; Boilson BA; Schirger JA; Clavell AL; Frantz RP; Tsutsui R; Liu M; Maltais S; Kushwaha SS; Pereira NL; Park SJ
    Circ Cardiovasc Imaging; 2011 Nov; 4(6):648-61. PubMed ID: 21940507
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preoperative Pectoralis Muscle Quantity and Attenuation by Computed Tomography Are Novel and Powerful Predictors of Mortality After Left Ventricular Assist Device Implantation.
    Teigen LM; John R; Kuchnia AJ; Nagel EM; Earthman CP; Kealhofer J; Martin C; Cogswell R
    Circ Heart Fail; 2017 Sep; 10(9):. PubMed ID: 28912261
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of concurrent surgical valve procedures in patients receiving continuous-flow devices.
    John R; Naka Y; Park SJ; Sai-Sudhakar C; Salerno C; Sundareswaran KS; Farrar DJ; Milano CA
    J Thorac Cardiovasc Surg; 2014 Feb; 147(2):581-9; discussion 589. PubMed ID: 24418362
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The aspartate transaminase/alanine transaminase (DeRitis) ratio predicts mid-term mortality and renal and respiratory dysfunction after left ventricular assist device implantation.
    Pilarczyk K; Carstens H; Heckmann J; Canbay A; Koch A; Pizanis N; Jakob H; Kamler M
    Eur J Cardiothorac Surg; 2017 Oct; 52(4):781-788. PubMed ID: 29156019
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcomes of left ventricular assist device implantation as destination therapy in the post-REMATCH era: implications for patient selection.
    Lietz K; Long JW; Kfoury AG; Slaughter MS; Silver MA; Milano CA; Rogers JG; Naka Y; Mancini D; Miller LW
    Circulation; 2007 Jul; 116(5):497-505. PubMed ID: 17638928
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of Bleeding Revision on Outcomes After Left Ventricular Assist Device Implantation.
    Angleitner P; Simon P; Kaider A; Wiedemann D; Dimitrov K; Schlöglhofer T; Rajek MA; Riebandt J; Laufer G; Zimpfer D
    Ann Thorac Surg; 2019 Aug; 108(2):517-523. PubMed ID: 30851258
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fatal Neurologic Dysfunction During Continuous-Flow Left Ventricular Assist Device Support.
    Kawabori M; Conyer RT; Kurihara C; Sugiura T; Civitello AB; Frazier OH; Morgan JA
    Ann Thorac Surg; 2019 Apr; 107(4):1132-1138. PubMed ID: 30465757
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors for early death in patients bridged to transplant with continuous-flow left ventricular assist devices.
    Arnaoutakis GJ; George TJ; Kilic A; Beaty CA; Weiss ES; Conte JV; Shah AS
    Ann Thorac Surg; 2012 May; 93(5):1549-54; discussion 1555. PubMed ID: 22429670
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Significance of postoperative acute renal failure after continuous-flow left ventricular assist device implantation.
    Borgi J; Tsiouris A; Hodari A; Cogan CM; Paone G; Morgan JA
    Ann Thorac Surg; 2013 Jan; 95(1):163-9. PubMed ID: 23103012
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence, predictors, and clinical impact of electrical storm in patients with left ventricular assist devices: New insights from the ASSIST-ICD study.
    Martins RP; Leclercq C; Bourenane H; Auffret V; Boulé S; Loobuyck V; Dambrin C; Mondoly P; Sacher F; Bordachar P; Kindo M; Cardi T; Gaudard P; Rouvière P; Michel M; Gourraud JB; Defaye P; Chavanon O; Kerneis C; Ghodhbane W; Pelcé E; Gariboldi V; Pozzi M; Grinberg D; Litzler PY; Anselme F; Babatasi G; Belin A; Garnier F; Bielefeld M; Hamon D; Lellouche N; Pierre B; Bourguignon T; Eschallier R; D'Ostrevy N; Bories MC; Jouan J; Vanhuyse F; Sadoul N; Flécher E; Galand V
    Heart Rhythm; 2019 Oct; 16(10):1506-1512. PubMed ID: 31255846
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of concomitant cardiac procedures performed during implantation of long-term left ventricular assist devices.
    Morgan JA; Tsiouris A; Nemeh HW; Hodari A; Karam J; Brewer RJ; Paone G
    J Heart Lung Transplant; 2013 Dec; 32(12):1255-61. PubMed ID: 24135274
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Postoperative hyperbilirubinemia after implantation of left ventricular assist device is associated with poor postoperative liver perfusion.
    Fujita Y; Fujino Y; Matsumiya G; Sawa Y; Mashimo T; Matsuda H; Nishimura M
    J Artif Organs; 2005; 8(1):28-33. PubMed ID: 15951977
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does elective or emergent operative status influence outcomes in patients undergoing implantation of left ventricular assist devices?
    Tsiouris A; Morgan JA; Nemeh HW; Hodari A; Shah R; Brewer RJ; Paone G
    Heart Surg Forum; 2014 Apr; 17(2):E64-72. PubMed ID: 24808443
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.